These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics]. Beischer W. Fortschr Med; 1982 Sep 02; 100(33):1508-12. PubMed ID: 7129312 [Abstract] [Full Text] [Related]
9. [The artificial endocrine pancreas in clinical medicine and in research]. Pfeiffer EF, Beischer W, Thum C, Clemens AH. Journ Annu Diabetol Hotel Dieu; 1976 May 02; ():279-96. PubMed ID: 796524 [No Abstract] [Full Text] [Related]
10. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. Block MB, Rosenfield RL, Mako ME, Steiner DF, Rubenstein AH. N Engl J Med; 1973 May 31; 288(22):1144-8. PubMed ID: 4633551 [No Abstract] [Full Text] [Related]
11. In vitro conversion of proinsulin to insulin by cathepsin B and role of C-peptide. Puri RB, Anjaneyulu K, Kidwai JR, Mohan Rao VK. Acta Diabetol Lat; 1978 May 31; 15(5-6):243-50. PubMed ID: 373354 [Abstract] [Full Text] [Related]
12. [Pancreatic B cell peptides: kinetic behaviour and concentrations of proinsulin, insulin and C-peptide in plasma and urine, problems of assay methods, clinical significance and literature review (author's transl)]. Gerbitz KD. J Clin Chem Clin Biochem; 1980 Jun 31; 18(6):313-26. PubMed ID: 7000969 [Abstract] [Full Text] [Related]
14. [Plasma insulin, C-peptide and glucose concentrations in type I diabetic children after a morning injection of insulin (author's transl)]. Desjeux JF, Vicq D, Gouedard H, Dieterlen P, Gernez-Lestradet C, Lestradet H. Arch Fr Pediatr; 1981 Jun 31; 38(6):411-5. PubMed ID: 7027987 [Abstract] [Full Text] [Related]
15. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy. Taskinen MR, Groop L. Ann Clin Res; 1984 Jun 31; 16(2):118-27. PubMed ID: 6380385 [No Abstract] [Full Text] [Related]
16. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application. Rosak C, Hofmann U, Paulwitz O. Diabetes Nutr Metab; 2004 Jun 31; 17(3):137-42. PubMed ID: 15334790 [Abstract] [Full Text] [Related]
17. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K. Am J Physiol Endocrinol Metab; 2003 Jul 31; 285(1):E155-62. PubMed ID: 12670835 [Abstract] [Full Text] [Related]